Emster Kurt Von
- SEC CIK
- 0001252524
No open-market purchases or sales filed in the past year.
Current role at each company
- JSPR Jasper Therapeutics, Inc.Directoras of Aug 4, 2026
- CBAY CymaBay Therapeutics, Inc.Directoras of Mar 22, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Emster Kurt Von as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CBAY CymaBay Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2023 (view filing) | Sep 29 | Same day | Emster Kurt VonDirector | SSale | −15.9K | $15.68 | −$249.6K | −15.0%90.0K after | 10b5-1 |
JSPR Jasper Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2023 (view filing) | Apr 13 | 1 day | Emster Kurt VonDirector | SSaleVoting Common Stock | −9.07K | $1.49 | −$13.5K | −30.0%21.2K after |